Prognostic Value of Admission Myeloperoxidase Levels in Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock
- 1 June 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 101 (11) , 1537-1540
- https://doi.org/10.1016/j.amjcard.2008.02.032
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary SyndromeThe American Journal of Cardiology, 2007
- Usefulness of the White Blood Cell Count as a Predictor of Angiographic Findings in an Unselected Population Referred for Coronary AngiographyThe American Journal of Cardiology, 2006
- Plasma Myeloperoxidase Levels in Patients With Chronic Heart FailureThe American Journal of Cardiology, 2006
- Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failurePublished by Elsevier ,2006
- Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized MyeloperoxidaseCirculation, 2006
- Myeloperoxidase and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Prognostic Value of Myeloperoxidase in Patients with Chest PainNew England Journal of Medicine, 2003
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of InflammationJournal of Biological Chemistry, 2002
- Treatment of myocardial infarction in a coronary care unitThe American Journal of Cardiology, 1967